MA23429A1 - NOVEL GALENIC FORM OF 5-NITRO IMIDAZOLE DERIVATIVES EFFECTIVE FOR THE TREATMENT OF PARASITOSIS AND INFECTIONS OF THE WHOLE TRACTUS-GASTROINTESTINAL. - Google Patents
NOVEL GALENIC FORM OF 5-NITRO IMIDAZOLE DERIVATIVES EFFECTIVE FOR THE TREATMENT OF PARASITOSIS AND INFECTIONS OF THE WHOLE TRACTUS-GASTROINTESTINAL.Info
- Publication number
- MA23429A1 MA23429A1 MA23756A MA23756A MA23429A1 MA 23429 A1 MA23429 A1 MA 23429A1 MA 23756 A MA23756 A MA 23756A MA 23756 A MA23756 A MA 23756A MA 23429 A1 MA23429 A1 MA 23429A1
- Authority
- MA
- Morocco
- Prior art keywords
- gastrointestinal
- tractus
- parasitosis
- infections
- whole
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Medicinal form contains a combination of microgranules of derivatives 5-nitroimidasole, consisting, on the one hand, of gastro-resistant microgranules and, on the other hand, of microgranules with a prolonged release of a medicinal agent. Gastroresistant microgranules are intended to guarantee the efficiency of the medicinal form of the present invention, primarily, in the upper part of gastrointestinal tract, while the microgranules with a prolonged medicinal agent release are operate mainly in the lower part of gastrointestinal tract.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9400394A FR2715067B1 (en) | 1994-01-14 | 1994-01-14 | New dosage form of 5-nitro-imidazole derivatives effective for the treatment of parasitic infections and infections of the entire gastrointestinal tract. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA23429A1 true MA23429A1 (en) | 1995-10-01 |
Family
ID=9459066
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA23756A MA23429A1 (en) | 1994-01-14 | 1995-01-13 | NOVEL GALENIC FORM OF 5-NITRO IMIDAZOLE DERIVATIVES EFFECTIVE FOR THE TREATMENT OF PARASITOSIS AND INFECTIONS OF THE WHOLE TRACTUS-GASTROINTESTINAL. |
Country Status (19)
| Country | Link |
|---|---|
| JP (1) | JPH09507499A (en) |
| KR (1) | KR100320140B1 (en) |
| CN (1) | CN1088357C (en) |
| AT (1) | ATE187068T1 (en) |
| AU (1) | AU705570B2 (en) |
| BR (1) | BR9506507A (en) |
| CZ (1) | CZ286080B6 (en) |
| DE (1) | DE69513632T2 (en) |
| DK (1) | DK0739201T3 (en) |
| ES (1) | ES2139883T3 (en) |
| MA (1) | MA23429A1 (en) |
| MX (1) | MX9602772A (en) |
| NZ (1) | NZ279238A (en) |
| OA (1) | OA10583A (en) |
| PL (1) | PL178424B1 (en) |
| PT (1) | PT739201E (en) |
| RU (1) | RU2152212C1 (en) |
| SK (1) | SK282066B6 (en) |
| UA (1) | UA28031C2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4331930B2 (en) * | 2001-10-17 | 2009-09-16 | 武田薬品工業株式会社 | High content granules of acid labile drugs |
| KR20190026962A (en) | 2014-09-05 | 2019-03-13 | 심바이오믹스 세러퓨틱스 엘엘씨 | Secnidazole for use in the treatment of bacterial vaginosis |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5256684A (en) * | 1985-06-13 | 1993-10-26 | The Procter & Gamble Company | Methods and compositions for the treatment of gastrointestinal disorders |
| DE3822095A1 (en) * | 1988-06-30 | 1990-01-04 | Klinge Co Chem Pharm Fab | NEW MEDICAMENT FORMULATION AND METHOD FOR THE PRODUCTION THEREOF |
| WO1991017744A1 (en) * | 1990-05-14 | 1991-11-28 | Jernberg Gary R | Surgical implant and method incorporating chemotherapeutic agents |
-
1995
- 1995-01-12 RU RU96117257/14A patent/RU2152212C1/en not_active IP Right Cessation
- 1995-01-12 UA UA96083232A patent/UA28031C2/en unknown
- 1995-01-12 AT AT95907683T patent/ATE187068T1/en not_active IP Right Cessation
- 1995-01-12 CN CN95191222A patent/CN1088357C/en not_active Expired - Fee Related
- 1995-01-12 DE DE69513632T patent/DE69513632T2/en not_active Expired - Fee Related
- 1995-01-12 PL PL95315530A patent/PL178424B1/en not_active IP Right Cessation
- 1995-01-12 BR BR9506507A patent/BR9506507A/en not_active IP Right Cessation
- 1995-01-12 PT PT95907683T patent/PT739201E/en unknown
- 1995-01-12 JP JP7518878A patent/JPH09507499A/en active Pending
- 1995-01-12 AU AU15803/95A patent/AU705570B2/en not_active Ceased
- 1995-01-12 MX MX9602772A patent/MX9602772A/en not_active IP Right Cessation
- 1995-01-12 DK DK95907683T patent/DK0739201T3/en active
- 1995-01-12 ES ES95907683T patent/ES2139883T3/en not_active Expired - Lifetime
- 1995-01-12 NZ NZ279238A patent/NZ279238A/en unknown
- 1995-01-12 SK SK914-96A patent/SK282066B6/en unknown
- 1995-01-12 KR KR1019960703797A patent/KR100320140B1/en not_active IP Right Cessation
- 1995-01-12 CZ CZ19962055A patent/CZ286080B6/en not_active IP Right Cessation
- 1995-01-13 MA MA23756A patent/MA23429A1/en unknown
-
1996
- 1996-07-12 OA OA60863A patent/OA10583A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| UA28031C2 (en) | 2000-10-16 |
| PL315530A1 (en) | 1996-11-12 |
| SK282066B6 (en) | 2001-10-08 |
| JPH09507499A (en) | 1997-07-29 |
| AU1580395A (en) | 1995-08-01 |
| DE69513632T2 (en) | 2000-04-06 |
| ES2139883T3 (en) | 2000-02-16 |
| OA10583A (en) | 2002-07-10 |
| AU705570B2 (en) | 1999-05-27 |
| DE69513632D1 (en) | 2000-01-05 |
| CZ286080B6 (en) | 2000-01-12 |
| RU2152212C1 (en) | 2000-07-10 |
| CN1088357C (en) | 2002-07-31 |
| SK91496A3 (en) | 1996-12-04 |
| CN1138826A (en) | 1996-12-25 |
| ATE187068T1 (en) | 1999-12-15 |
| BR9506507A (en) | 1997-09-09 |
| MX9602772A (en) | 1997-05-31 |
| KR100320140B1 (en) | 2002-07-02 |
| CZ205596A3 (en) | 1996-10-16 |
| PL178424B1 (en) | 2000-04-28 |
| DK0739201T3 (en) | 2000-05-01 |
| PT739201E (en) | 2000-05-31 |
| NZ279238A (en) | 1998-03-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI265808B (en) | Valdecoxib compositions | |
| TR200002773T2 (en) | Smilagen and anzurogenin-D and their use for the treatment of Alzheimer's. | |
| DE60143393D1 (en) | MODIFIED FORMS PHARMACEUTICALLY ACTIVE AGENTS AND USES THEREOF | |
| NZ334124A (en) | Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease | |
| HUP0102033A2 (en) | Use of peg-ifn-alpha and ribavirin for the treatment of chronic hepatitis c | |
| DE69905368D1 (en) | Oxydiertes thymosin beta 4 | |
| DZ3014A1 (en) | Medicines for the treatment of hypertension. | |
| SV2002000235A (en) | PHARMACEUTICAL COMPOSITIONS THAT INCLUDE VALDECOXIB | |
| MA26777A1 (en) | AMINOTRANSFERASE INHIBITORS DEPENDENT ON AMINO ACID IN BRANCHED CHAIN AND THEIR USE IN THE TREATMENT OF DIABETIC RETINOPATHY. | |
| MX9707642A (en) | Pharmaceutical agents for the treatment of alzheimer's disease. | |
| MA23429A1 (en) | NOVEL GALENIC FORM OF 5-NITRO IMIDAZOLE DERIVATIVES EFFECTIVE FOR THE TREATMENT OF PARASITOSIS AND INFECTIONS OF THE WHOLE TRACTUS-GASTROINTESTINAL. | |
| DZ1988A1 (en) | Combination therapy for the treatment of winter. | |
| EA200000909A1 (en) | FORM VI 5,6-DICHLOR-2- (ISOPROPYLAMINO) -1- (b-L-RIBOFURANOSIL) -1H-BENZIMIDAZOLE | |
| TR199802200A2 (en) | S �lfonamid s �bstit �e edilmi � benzopiran t �revleri, �retilme y �ntemi. | |
| DZ3320A1 (en) | Complex comprising eletriptane and sulphobutylether-cyclodextrin for the treatment of migraine | |
| RU99127647A (en) | MEANS FOR TREATMENT OF SEXUAL DYSFUNCTIONS IN MEN | |
| WO1999020259A3 (en) | Compositions containing thiamphenicol and diclofenac | |
| FR2720944B1 (en) | Therapeutic or dietetic composition in the form of a medicated gel for administration to pets. | |
| FR2802101B1 (en) | COMBINATION OF CYMEMAZINE AND AN ATYPICAL NEUROLEPTIC | |
| TR199701605A2 (en) | S�lfonamid-substit�e edilmi� bile�ikler | |
| GB9209599D0 (en) | Novel therapy for the treatment of parkinsons disease | |
| FR2709964B1 (en) | Antiviral pharmaceutical compositions proposed in the treatment of AIDS and Herpes. | |
| TNSN00242A1 (en) | VALDECOXIB COMPOSITIONS | |
| DE60040856D1 (en) | Lactalbumin for the curative treatment of gastric ulcers | |
| ES2150400A6 (en) | Pharmaceutical composition for treatment of ulcer type disorders of gastro-intestinal tract, comprises methyl polysiloxanol and solvent or carrier pharmaceutically acceptable for oral use |